S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   421.77 (-0.39%)
AAPL   165.45 (-0.95%)
MSFT   402.79 (-0.37%)
META   494.61 (-1.43%)
GOOGL   154.86 (-0.74%)
AMZN   177.91 (-0.73%)
TSLA   148.66 (-0.85%)
NVDA   839.38 (-0.87%)
AMD   153.36 (-1.11%)
NIO   3.86 (-3.50%)
BABA   68.71 (-0.25%)
T   16.39 (+0.37%)
F   12.18 (+1.00%)
MU   109.70 (-1.99%)
GE   152.93 (+-0.01%)
CGC   8.22 (+4.98%)
DIS   112.24 (-0.17%)
AMC   3.07 (+5.14%)
PFE   25.45 (+0.24%)
PYPL   62.09 (-0.02%)
XOM   120.08 (+1.32%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   421.77 (-0.39%)
AAPL   165.45 (-0.95%)
MSFT   402.79 (-0.37%)
META   494.61 (-1.43%)
GOOGL   154.86 (-0.74%)
AMZN   177.91 (-0.73%)
TSLA   148.66 (-0.85%)
NVDA   839.38 (-0.87%)
AMD   153.36 (-1.11%)
NIO   3.86 (-3.50%)
BABA   68.71 (-0.25%)
T   16.39 (+0.37%)
F   12.18 (+1.00%)
MU   109.70 (-1.99%)
GE   152.93 (+-0.01%)
CGC   8.22 (+4.98%)
DIS   112.24 (-0.17%)
AMC   3.07 (+5.14%)
PFE   25.45 (+0.24%)
PYPL   62.09 (-0.02%)
XOM   120.08 (+1.32%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   421.77 (-0.39%)
AAPL   165.45 (-0.95%)
MSFT   402.79 (-0.37%)
META   494.61 (-1.43%)
GOOGL   154.86 (-0.74%)
AMZN   177.91 (-0.73%)
TSLA   148.66 (-0.85%)
NVDA   839.38 (-0.87%)
AMD   153.36 (-1.11%)
NIO   3.86 (-3.50%)
BABA   68.71 (-0.25%)
T   16.39 (+0.37%)
F   12.18 (+1.00%)
MU   109.70 (-1.99%)
GE   152.93 (+-0.01%)
CGC   8.22 (+4.98%)
DIS   112.24 (-0.17%)
AMC   3.07 (+5.14%)
PFE   25.45 (+0.24%)
PYPL   62.09 (-0.02%)
XOM   120.08 (+1.32%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   421.77 (-0.39%)
AAPL   165.45 (-0.95%)
MSFT   402.79 (-0.37%)
META   494.61 (-1.43%)
GOOGL   154.86 (-0.74%)
AMZN   177.91 (-0.73%)
TSLA   148.66 (-0.85%)
NVDA   839.38 (-0.87%)
AMD   153.36 (-1.11%)
NIO   3.86 (-3.50%)
BABA   68.71 (-0.25%)
T   16.39 (+0.37%)
F   12.18 (+1.00%)
MU   109.70 (-1.99%)
GE   152.93 (+-0.01%)
CGC   8.22 (+4.98%)
DIS   112.24 (-0.17%)
AMC   3.07 (+5.14%)
PFE   25.45 (+0.24%)
PYPL   62.09 (-0.02%)
XOM   120.08 (+1.32%)

Tarsus Pharmaceuticals (TARS) News Today

$33.05
+0.20 (+0.61%)
(As of 09:56 AM ET)
SourceHeadline
finance.yahoo.com logoInsider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14%
finance.yahoo.com - April 19 at 8:16 AM
marketbeat.com logoQ1 2024 EPS Estimates for Tarsus Pharmaceuticals, Inc. Boosted by Analyst (NASDAQ:TARS)
marketbeat.com - April 19 at 8:16 AM
MarketBeat logoTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Average Rating of "Moderate Buy" from Brokerages
americanbankingnews.com - April 18 at 2:14 AM
MarketBeat logoTarsus Pharmaceuticals (NASDAQ:TARS) Shares Down 5.2%
americanbankingnews.com - April 14 at 4:42 AM
marketbeat.com logoVanguard Group Inc. Has $27.58 Million Stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
marketbeat.com - April 13 at 4:30 AM
marketbeat.com logoTarsus Pharmaceuticals (NASDAQ:TARS) Trading Down 5.2%
marketbeat.com - April 12 at 2:51 PM
marketbeat.com logoTarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Up 6.1%
marketbeat.com - April 11 at 4:01 PM
finance.yahoo.com logoWall Street Analysts Predict a 47.12% Upside in Tarsus Pharmaceuticals (TARS): Here's What You Should Know
finance.yahoo.com - April 8 at 2:09 PM
msn.com logoScientists share trial results for new tick-repelling drug for humans: 'An amazing opportunity'
msn.com - April 6 at 2:18 AM
marketbeat.com logoTarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Up 6.3%
marketbeat.com - March 28 at 7:27 PM
investing.com logoTarsus Pharmaceuticals executive sells over $130k in company stock
investing.com - March 21 at 8:19 PM
investing.com logoTarsus Pharmaceuticals exec sells over $135k in stock
investing.com - March 21 at 8:19 PM
insidertrades.com logoBryan Wahl Sells 4,436 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Stock
insidertrades.com - March 20 at 6:52 AM
marketbeat.com logoInsider Selling: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) General Counsel Sells 4,436 Shares of Stock
marketbeat.com - March 19 at 8:14 PM
msn.com logoPill Targeting Tick-Induced Lyme Disease Shows Promise in Human Trials
msn.com - March 18 at 2:35 AM
finance.yahoo.com logoTARS Apr 2024 25.000 call
finance.yahoo.com - March 16 at 2:01 PM
finance.yahoo.com logoTARS Apr 2024 17.500 put
finance.yahoo.com - March 16 at 1:17 AM
finance.yahoo.com logoTARS Apr 2024 12.500 call
finance.yahoo.com - March 16 at 1:17 AM
marketbeat.com logoTarsus Pharmaceuticals (NASDAQ:TARS) Shares Up 6.9%
marketbeat.com - March 15 at 12:37 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: ProQR (PRQR) and Crinetics Pharmaceuticals (CRNX)
markets.businessinsider.com - March 13 at 7:29 PM
marketbeat.com logoTarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Down 5.7%
marketbeat.com - March 11 at 12:44 PM
marketbeat.com logoTarsus Pharmaceuticals (NASDAQ:TARS) Price Target Increased to $44.00 by Analysts at Jefferies Financial Group
marketbeat.com - March 7 at 8:20 AM
marketbeat.com logoRTW Investments LP Grows Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
marketbeat.com - March 6 at 11:00 AM
globenewswire.com logoTarsus to Participate at Upcoming Investor Conferences
globenewswire.com - March 5 at 4:30 PM
globenewswire.com logoTarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
globenewswire.com - March 5 at 8:30 AM
marketbeat.com logoConnor Clark & Lunn Investment Management Ltd. Makes New Investment in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
marketbeat.com - March 4 at 6:02 AM
marketbeat.com logoTarsus Pharmaceuticals (NASDAQ:TARS) Sees Unusually-High Trading Volume Following Analyst Upgrade
marketbeat.com - March 3 at 1:03 AM
investing.com logoTarsus Pharmaceuticals launches $100 million stock offering
investing.com - March 2 at 8:15 AM
finance.yahoo.com logoTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates
finance.yahoo.com - March 1 at 5:07 PM
marketbeat.com logoTarsus Pharmaceuticals (NASDAQ:TARS) Sees Large Volume Increase on Analyst Upgrade
marketbeat.com - March 1 at 10:15 AM
msn.com logoTarsus Pharmaceuticals stock dips after pricing $100M securities offering
msn.com - March 1 at 7:05 AM
marketwatch.com logoTarsus Pharmaceuticals Shares Slip Premarket After Stock Offering
marketwatch.com - March 1 at 7:05 AM
marketbeat.com logoQ1 2024 EPS Estimates for Tarsus Pharmaceuticals, Inc. Raised by Analyst (NASDAQ:TARS)
marketbeat.com - March 1 at 6:36 AM
marketbeat.com logoTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Acquired by Swiss National Bank
marketbeat.com - March 1 at 4:17 AM
globenewswire.com logoTarsus Announces Pricing of $100.0 Million Public Offering
globenewswire.com - March 1 at 12:07 AM
seekingalpha.com logoTarsus Pharmaceuticals, Inc. (TARS) Q4 2023 Earnings Call Transcript
seekingalpha.com - February 29 at 10:48 PM
marketwatch.com logoTarsus Pharmaceuticals Shares Fall 11% After Public Offering News
marketwatch.com - February 29 at 10:48 PM
msn.com logoTarsus announces proposed $100M public offering
msn.com - February 29 at 5:47 PM
globenewswire.com logoTarsus Announces Proposed $100.0 Million Public Offering
globenewswire.com - February 29 at 4:37 PM
marketbeat.com logoTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Forecasted to Post Q1 2025 Earnings of ($1.36) Per Share
marketbeat.com - February 29 at 8:53 AM
finance.yahoo.com logoParty Time: Brokers Just Made Major Increases To Their Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Earnings Forecasts
finance.yahoo.com - February 29 at 7:47 AM
markets.businessinsider.com logoBuy Rating Affirmed: Tarsus Pharmaceuticals’ Strong Q4 and Robust Pipeline Fuel Upward Price Revision
markets.businessinsider.com - February 28 at 1:08 PM
finance.yahoo.com logoTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 28 at 1:08 PM
marketbeat.com logoTarsus Pharmaceuticals (NASDAQ:TARS) Announces Earnings Results, Beats Expectations By $0.06 EPS
marketbeat.com - February 28 at 10:42 AM
marketbeat.com logoTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Consensus Rating of "Moderate Buy" by Brokerages
marketbeat.com - February 28 at 9:46 AM
marketbeat.com logoTarsus Pharmaceuticals (NASDAQ:TARS) Stock Rating Reaffirmed by Oppenheimer
marketbeat.com - February 28 at 8:30 AM
finance.yahoo.com logoTarsus Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
finance.yahoo.com - February 28 at 8:08 AM
finance.yahoo.com logoQ4 2023 Tarsus Pharmaceuticals Inc Earnings Call
finance.yahoo.com - February 28 at 1:41 AM
marketwatch.com logoTarsus Pharmaceuticals Shares Rise 13% On Product Sales
marketwatch.com - February 27 at 3:41 PM
marketbeat.com logoTarsus Pharmaceuticals (NASDAQ:TARS) Shares Gap Up to $33.16
marketbeat.com - February 27 at 11:48 AM
Get Tarsus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TARS and its competitors with MarketBeat's FREE daily newsletter.

I’m officially sounding the alarm. (Ad)

AI has been the hottest financial story of 2023. And rightly so – AI stocks have beat the broader market by over 62%. But right now, my system is warning me that many AI stocks are riding higher on hype alone.

Just click here to watch my full uncensored interview.

TARS Media Mentions By Week

TARS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TARS
News Sentiment

0.84

0.52

Average
Medical
News Sentiment

TARS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TARS Articles
This Week

7

3

TARS Articles
Average Week

Get Tarsus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TARS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:TARS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners